Appears On
Episode Appearances
The a16z Show · Mar 9, 2026
Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
“Stanford researcher studying rejuvenating factors in young blood and exercise”
GLP-1 drugs and obesity treatmentPeptide therapy and gray market sourcingSleep technology and circadian biology
View AnalysisThe Peter Attia Drive · Aug 4, 2025
#359 ‒ How metabolic and immune system dysfunction drive the aging process, the role of NAD, promising interventions, aging clocks, and more | Eric Verdin, M.D.
“Developed proteomics-based aging clocks and organ-specific biomarkers from blood plasma”
NAD metabolism and CD38 inhibitionEpigenetic aging clocks and their limitationsThymic involution and immune aging
View Analysis